Advanced formulations for improving therapies with anti-inflammatory or anaesthetic drugs: A review

被引:20
|
作者
Maestrelli, Francesca [1 ]
Bragagni, Marco [1 ]
Mura, Paola [1 ]
机构
[1] Univ Florence, Dept Chem, Via Ugo Schiff 6, I-50019 Florence, Italy
关键词
Micro- and nanotechnologies in pain management; Cyclodextrin complexation; Solid dispersions; Vesicular systems; Micro and nanoparticles; Microemulsions; HYDROXYPROPYL-BETA-CYCLODEXTRIN; SOLID LIPID NANOPARTICLES; IN-VITRO EVALUATION; SUPERCRITICAL CARBON-DIOXIDE; TYPED LOCAL-ANESTHETICS; WATER-SOLUBLE DRUG; PHYSICOCHEMICAL CHARACTERIZATION; DISSOLUTION PROPERTIES; INCLUSION COMPLEXATION; STATE CHARACTERIZATION;
D O I
10.1016/j.jddst.2015.09.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The development of new more effective therapeutic treatments for pain relief is essential for enhancing the patient quality of life and safety and avoiding or limiting risks of abuse, addiction or serious injuries posed by some of the present pain therapies. With this aim, in the last years, several advanced delivery systems have been developed to increase bioavailability, therapeutic efficacy and safety of well known analgesics, overcoming limits and drawbacks of traditional formulations. Among the different kinds of drugs used in the treatment of pain, non-opioid drugs such as local anaesthetics, corticosteroids and non steroidal anti-inflammatory drugs are preferred in the treatment of mild or moderate pain. However, each of these classes is associated with different adverse events and inconveniences, most of which could be reduced or overcome by appropriate drug carrier systems. This review is focused on recent drug delivery strategies based on micro- and nano-technologies developed for improving the effectiveness in pain management through non-opioid agents, exploiting different approaches such as: cyclodextrin complexation, solid dispersions with hydrophilic polymers, mechano-chemically activated systems, micro and nanoparticles, micro and nano-emulsions, vesicular systems. Combined approaches, simultaneously exploiting the relative advantages of such systems in a single drug delivery device, were also reviewed. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:192 / 205
页数:14
相关论文
共 50 条
  • [21] Reactivity of nonsteroidal anti-inflammatory drugs with peroxidase: a classification of nonsteroidal anti-inflammatory drugs
    Miura, Toshiaki
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (10) : 1461 - 1471
  • [22] Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs
    Cubillos-Angulo, Juan M. M.
    Nogueira, Betania M. F.
    Arriaga, Maria B.
    Barreto-Duarte, Beatriz
    Araujo-Pereira, Mariana
    Fernandes, Catarina D. D.
    Vinhaes, Caian L. L.
    Villalva-Serra, Klauss
    Nunes, Vanessa M. M.
    Miguez-Pinto, Joao P.
    Amaral, Eduardo P. P.
    Andrade, Bruno B. B.
    FRONTIERS IN MEDICINE, 2022, 9
  • [23] ACTIONS OF ANTI-INFLAMMATORY DRUGS
    LANDS, WEM
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (03) : 78 - 80
  • [24] QSAR of anti-inflammatory drugs
    Veronica R Khayrullina
    H Bögel
    Journal of Cheminformatics, 2 (Suppl 1)
  • [25] Improving the treatment for depressive symptoms and major depression with anti-inflammatory drugs
    Zunszain, Patricia A.
    EVIDENCE-BASED MENTAL HEALTH, 2015, 18 (04) : 116 - 116
  • [26] SCREENS FOR ANTI-INFLAMMATORY DRUGS
    ROSA, MD
    WILLOUGH.DA
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1971, 23 (04) : 297 - &
  • [27] NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    CLOHS, L
    KOROLKOVAS, A
    REVISTA BRASILEIRA DE MEDICINA, 1988, 45 (10) : 413 - 417
  • [28] NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    WOLF, RE
    ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (08) : 1658 - 1660
  • [29] Nonsteroidal anti-inflammatory drugs
    Gotzsche, PC
    AMERICAN FAMILY PHYSICIAN, 2006, 73 (03) : 507 - 508
  • [30] Anti-inflammatory drugs and atherosclerosis
    Moubayed, Sarni P.
    Heinonen, Therese M.
    Tardif, Jean-Claude
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (06) : 638 - 644